High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma (vol 100, pg 1444, 2009)

被引:0
|
作者
Marechal, R.
Demetter, P.
Nagy, N.
Berton, A.
Decaestecker, C.
Polus, M.
Closset, J.
Deviere, J.
Salmon, I.
Van Laethem, J-L
机构
关键词
D O I
10.1038/sj.bjc.6605894
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Correction to: British Journal of Cancer (2009) 100, 1444–1451. doi:10.1038/sj.bjc.6605020 Upon publication of this paper in 2009, the authors noticed two errors – one in the abstract and one within the Results section. On page 1444 (Abstract), the seventh sentence should read as follows: ‘In a combining analysis, patients with a CXCR7high/CXCR4high tumour had a significantly shorter DFS and OS than patients with a CXCR4low/CXCR7low tumour’.
引用
收藏
页码:930 / 930
页数:1
相关论文
共 50 条
  • [21] High expression of CXCR4 is associated with lower biochemical recurrence rate in prostate adenocarcinoma
    Choi, C.
    Kim, S. -S.
    Hwang, E. -C.
    Kwon, D. -D.
    VIRCHOWS ARCHIV, 2015, 467 : S265 - S266
  • [22] Glutathione peroxidase 4 expression predicts poor overall survival in patients with resected lung adenocarcinoma
    Liu, Chao-Yu
    Liu, Chen-Chi
    Li, Anna Fen-Yau
    Hsu, Tien-Wei
    Lin, Jiun-Han
    Hung, Shih-Chieh
    Hsu, Han-Shui
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Glutathione peroxidase 4 expression predicts poor overall survival in patients with resected lung adenocarcinoma
    Chao-Yu Liu
    Chen-Chi Liu
    Anna Fen-Yau Li
    Tien-Wei Hsu
    Jiun-Han Lin
    Shih-Chieh Hung
    Han-Shui Hsu
    Scientific Reports, 12
  • [24] CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer
    Gardner, Kirby P.
    Tsai, Susan
    Aldakkak, Mohammed
    Gironda, Stephen
    Adams, Daniel L.
    PLOS ONE, 2022, 17 (03):
  • [25] Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma
    Oda, Yoshinao
    Tateishi, Naomi
    Matono, Hiroshi
    Matsuura, Suguru
    Yamamaoto, Hidetaka
    Tamiya, Sadafumi
    Yokoyama, Ryohei
    Matsuda, Shuichi
    Iwamoto, Yukihide
    Tsuneyoshi, Masazumi
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (08) : 1852 - 1859
  • [26] High CXCR4 expression in pancreatic ductal adenocarcinoma as characterized by an inflammatory tumor phenotype with potential implications for an immunotherapeutic approach.
    Seeber, Andreas
    Kocher, Florian
    Pircher, Andreas
    Puccini, Alberto
    Baca, Yasmine
    Xiu, Joanne
    Zimmer, Kai
    Haybaeck, Johannes
    Spizzo, Gilbert
    Goldberg, Richard M.
    Grothey, Axel
    Shields, Anthony Frank
    Salem, Mohamed E.
    Marshall, John
    Hall, Michael J.
    Korn, Wolfgang Michael
    Nabhan, Chadi
    Battaglin, Francesca
    Lenz, Heinz-Josef
    Wolf, Dominik Georg Friedrich
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Reduced CXCR4 expression in associated with extramedullary and predicts poor survival in newly diagnosed multiple myeloma
    Chen, Dangui
    Zhan, Yang
    Yan, Hong
    Liang, Hong
    Yao, Fusheng
    Xu, Haitao
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (11) : 1017 - 1021
  • [28] Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
    Kim, J
    Takeuchi, H
    Lam, ST
    Turner, RR
    Wang, HJ
    Kuo, C
    Foshag, L
    Bilchik, AJ
    Hoon, DSB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2744 - 2753
  • [29] Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma
    Yan, Ting-Ting
    Fu, Xue-Liang
    Li, Jiao
    Bian, Ying-Nan
    Liu, De-Jun
    Hua, Rong
    Ren, Lin-Lin
    Li, Cheng-Tao
    Sun, Yong-Wei
    Chen, Hao-Yan
    Fang, Jing-Yuan
    Hong, Jie
    ONCOTARGET, 2015, 6 (35) : 37028 - 37042
  • [30] Can Expression of CXCL12 and CXCR4 Be Used to Predict Survival of Gastric Cancer Patients?
    Satomura, Hitoshi
    Sasaki, Kinro
    Nakajima, Masanobu
    Yamaguchi, Satoru
    Onodera, Shinichi
    Otsuka, Kichiro
    Takahashi, Masakazu
    Muroi, Hiroto
    Shida, Yosuke
    Ogata, Hideo
    Okamoto, Kentaro
    Kato, Hiroyuki
    ANTICANCER RESEARCH, 2014, 34 (08) : 4051 - 4057